蓝丰生化(002513) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 500,263,367.26, an increase of 26.17% year-on-year [8]. - Net profit attributable to shareholders was CNY 20,547,439.61, a significant increase of 260.46% compared to the same period last year [8]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 6,168,109.86, up 568.42% year-on-year [8]. - Basic earnings per share for the reporting period were CNY 0.06, representing a 200.00% increase compared to the previous year [8]. - The total comprehensive income for Q3 2020 was ¥20,547,439.61, up from ¥5,700,314.40 in Q3 2019, indicating a substantial increase of 260.5% [50]. - Net profit for Q3 2020 was ¥20,547,439.61, compared to ¥5,700,314.40 in Q3 2019, representing an increase of 260.5% [49]. - The total profit for the period was ¥12,872,580.03, a decrease of 64.12% from ¥35,854,446.86 in the previous period [56]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,560,541,590.75, a decrease of 5.26% compared to the end of the previous year [8]. - Current assets decreased from CNY 814,771,310.26 to CNY 715,382,524.82, a decline of approximately 12.2% [39]. - Total liabilities decreased from CNY 1,567,332,363.53 to CNY 1,416,786,871.54, a decline of about 9.6% [41]. - Long-term borrowings decreased from CNY 9,212,865.72 to zero, indicating a complete repayment [41]. - Total equity increased to ¥2,284,646,985.13 from ¥2,269,311,590.15, showing a growth of 0.7% [48]. Cash Flow - The net cash flow from operating activities was negative CNY 37,644,530.96, a decrease of 371.41% compared to the same period last year [8]. - Cash inflow from operating activities was CNY 1,014,064,509.71, down from CNY 1,128,919,196.96, indicating a decline of about 10.2% year-over-year [63]. - The net cash flow from operating activities was CNY 27,765,369.26, significantly lower than CNY 187,288,617.41 from the previous year, representing a decrease of approximately 85.2% [65]. - Cash outflow from investing activities totaled CNY 49,617,740.33, compared to CNY 95,745,491.51 in the previous year, showing a reduction of about 48.2% [66]. - The ending balance of cash and cash equivalents was CNY 76,480,304.41, down from CNY 100,336,597.45, reflecting a decrease of about 23.7% [66]. Shareholder Information - The company reported a total of 13,225 shareholders at the end of the reporting period [12]. - Jiangsu Suhua Group Co., Ltd. held 20.09% of the shares, making it the largest shareholder [12]. Research and Development - Research and development expenses decreased by 48.53% year-on-year, mainly due to a reduction in R&D projects [16]. - The company is investing 100 million yuan in R&D for innovative biochemicals over the next two years [23]. - Research and development expenses decreased significantly to ¥894,930.89 from ¥7,905,063.37, a reduction of 88.7% [48]. Market and Product Development - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2022 [25]. - New product development includes a line of eco-friendly pesticides, expected to launch in Q1 2021, projected to contribute an additional 200 million yuan in revenue [22]. - Jiangsu Lanfeng is exploring potential acquisitions in the agricultural sector to enhance its product portfolio and market reach [24]. Other Financial Information - The company did not engage in any repurchase transactions during the reporting period [13]. - There were no securities investments or derivative investments during the reporting period [30][31]. - The company has no non-operating fund occupation by controlling shareholders or their affiliates during the reporting period [34]. - The company has not engaged in any major contracts or entrusted financial management during the reporting period [32][35]. - The company committed to returning all occupied company funds and interest by December 31, 2018, but has not fulfilled this commitment [28]. - The company has not received any performance compensation payments for unfulfilled commitments as of December 31, 2018 [27]. - The company has no violations regarding external guarantees during the reporting period [33]. - The company has not conducted any research, communication, or interview activities during the reporting period [35]. - The company is committed to ensuring its legal rights based on the effective court documents received [29].